 19. Any condition that impairs a patients ability to swallow whole pills. Impairment of gastrointestinal function GI or GI disease that may significantly alter the absorption of lenalidomide e.g., ulcerative disease, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection. 